Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNYNF) Research & Development (2016 - 2025)

Historic Research & Development for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to -$9.1 billion.

  • Sanofi's Research & Development fell 1554.28% to -$9.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$19.7 billion, marking a year-over-year decrease of 4592.41%. This contributed to the annual value of -$8.9 billion for FY2025, which is 1073.94% down from last year.
  • Sanofi's Research & Development amounted to -$9.1 billion in Q4 2025, which was down 1554.28% from -$6.5 billion recorded in Q3 2025.
  • Over the past 5 years, Sanofi's Research & Development peaked at -$1.5 billion during Q1 2021, and registered a low of -$9.1 billion during Q4 2025.
  • For the 5-year period, Sanofi's Research & Development averaged around -$3.2 billion, with its median value being -$1.8 billion (2021).
  • Per our database at Business Quant, Sanofi's Research & Development tumbled by 754204.2% in 2021 and then crashed by 32.6% in 2023.
  • Over the past 5 years, Sanofi's Research & Development (Quarter) stood at -$1.8 billion in 2021, then crashed by 277.33% to -$6.8 billion in 2022, then fell by 2.33% to -$7.0 billion in 2023, then dropped by 12.86% to -$7.9 billion in 2024, then decreased by 15.54% to -$9.1 billion in 2025.
  • Its Research & Development stands at -$9.1 billion for Q4 2025, versus -$6.5 billion for Q3 2025 and -$2.2 billion for Q2 2025.